Last Updated on Sep 6, 2022 by Anjali Chourasiya

This article is authored by Kunal Rambhia, a fund manager at The Streets, a private fund. He has been in the equity market since 2010, in various roles such as Associate Research Analyst, Research Analyst, and Associate Portfolio Manager. He has media appearances with CNBC and ET NOW and is a visiting faculty in multiple colleges.

Markets have turned stock specifics. Extra strength is witnessed on indices, and counters have done good so far. Till we get further clarity, I would prefer to go stock specifics where the risk-reward is favourable, and bargain bets are available. One of such counters is Aarti Drugs. Let’s go through all observations. 

Monthly: Time cycle

When natural cycles are not clearly visible, then taking the help of Fibonacci makes a lot of sense. The first swing is taken to plot Fibonacci lines on the monthly chart. We can see multiple waves exactly near to/onto turning waves. Such time is due again in the present month/coming month for Aarti Drugs. Worth keeping an eye on this. 


Monthly: Channels

Since its inception, the counter has just moved perfectly within channels. All channels have just perfectly made a positive trend, making higher tops and higher bottoms. On channel breakout, the strong trend of decades may continue again. 

Weekly: Fibonacci

A massive rally was witnessed in the counter during 2020, and the correction began after making top during September 2020. The correction seems to be ending near 61.8% as the price is entering consolidation. Sideways consolidation of more than six months is adding more conviction. 

Weekly: RSI

Curve formation on the weekly chart coincides with rising RSI. The beginning of the curve had a rising RSI, which is still continuing upside. This bullish divergence is icing on the cake during decent consolidation. 


Weekly: MACD

MACD is a lagging indicator. After a massive run-up, MACD crossover confirmed the top in place. After a sizeable decline, MACD is turning upward from extreme lows. Crossover, along with bullish divergence on a lagging indicator, is making the counter more attractive. 

Weekly: Supertrend

Another indicator following the trend is the supertrend. Supertrend offers support and resistance. The most recent bounce on the counter exactly halted on Supertrend. The best trade can be the time when the price breakout is confirmed. For trend followers, it would make sense to wait for the breakout of the 490 zones. 

Daily: Price action & RSI

Massive curve formation on the daily chart and higher bottom of RSI is forming a situation of bullish divergence. In curve formation, it would always make sense to avoid breakouts and prefer to add on support. 

Daily: Ichimoku

Another indicator following a fantastic trend is Ichimoku. Multiple ways to read indicators, out of which one is Kumo Cloud crossover. Price attempted Cloud breakout during April 2022 but failed. This time, it has given breakout and sustained too. Cloud breakout is the first sign of trend reversal, and follow-through will confirm the rally. 

Putting it all together

Fibonacci cycle plotting on the monthly chart, channel formations since inception on the same higher timeframe, Fibonacci retracement of 61.8% of the last rally, bullish RSI divergence on the weekly chart and bullish divergence & crossover on MACD are making the counter very attractive. Supertrend breakout has to be kept in mind for trend followers. The curve formation with bullish RSI divergence and cloud breakout of Ichimoku on the daily chart is making it worth considering, even from a short-term point of view. 

Statutory Disclosure: Kindly note that this update is only for educational purposes. It is safe to assume that my personal position, my fund’s position, my client’s position and my relative’s position may be open on the counter. Prefer to take the advice of your financial advisor before initiating any position. 

Kunal Rambhia
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

The blog posts/articles on our platform are purely the author’s personal opinion and do not necessarily represent the views of Anchorage Technologies Private Limited (ATPL) or any of its associates. The content in these posts/articles is for informational and educational purposes only and should not be construed as professional financial advice. Should you need such advice, please consult a professional financial or tax advisor. The content on our platform may include opinions, analysis, or commentary, which are subject to change, without notice, based on market conditions or other factors. Further, the use of any third-party websites or services linked on the website is at the user's discretion and risk. ATPL is not responsible for the content, accuracy, or security of external sites. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. The examples and/or securities quoted (if any) are for illustration only and are not recommendatory. Any reliance you place on such information is strictly at your own risk. In no event will ATPL be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

By accessing this platform and its blog section, you acknowledge and agree to the Terms and Conditions of this website, Privacy Policy and Disclaimer.